Molinda Kearns

Molinda Kearns is a distinguished professor and seasoned pharmaceutical scientist specializing in lipid gene therapy delivery systems.

With a wealth of experience in physicochemical and biophysical analysis of lipidic drug delivery systems, Molinda Kearns is a recognized expert in her field.

In addition to her research pursuits, Molinda excels in the classroom by integrating chemistry and biology, offering students insight into both basic theory and advanced biotechnological applications.

Her extensive pharmaceutical research expertise includes developing lipid genetic delivery systems for gene therapy, formulating suspended charged and pH-responsive parenteral compositions, and characterizing cationic compounds for siRNA delivery.

Molinda Kearns is skilled in stability analysis of suspensions, mammalian cell line design, liposome analysis covering size distribution, zeta potential, pKa, charge displacement, loading efficiency, and toxicity, as well as conducting dose-response studies and developing structure-activity profiles.

Moreover, she is adept at performing biophysical profile analyses and has been involved in securing NIH grants for various projects.

Molinda Kearns completed her educational journey with a BS in Biological Sciences from D'Youville College, an MS in Molecular Biology from Long Island University, and a Ph.D. in Pharmaceutical Sciences with a focus on Applied Lipid Research and Gene Therapy from Long Island University, College of Pharmacy.

Throughout her career, Molinda has held significant roles in various organizations, such as co-owner of Hudson Anchor Restaurant, Chair of The Natural Sciences at Concordia College New York, Associate Professor of Chemistry and Biology at Concordia College New York, Adjunct Professor of Physical Sciences at City University of New York, and Research Fellow in Pathology at Albert Einstein College of Medicine.

Her early career saw her as a graduate student pursuing both her MS and Ph.D. degrees at Long Island University.